Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials.
Takashi ShigematsuRyoichi MuraokaToshitsugu SugimotoYoshiki NishizawaPublished in: BMC nephrology (2017)
The risedronate therapy showed similar clinical effects in CKD patients with osteoporosis compared to those without CKD.